Title |
Creatine for amyotrophic lateral sclerosis/motor neuron disease
|
---|---|
Published in |
Cochrane database of systematic reviews, December 2012
|
DOI | 10.1002/14651858.cd005225.pub3 |
Pubmed ID | |
Authors |
Daniel M Pastula, Dan H Moore, Richard S Bedlack |
Abstract |
Creatine, a naturally-occurring nitrogenous organic acid involved in adenosine triphosphate (ATP) production, has been shown to increase survival in mouse models of amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND). Results from human trials, however, have been mixed. Given conflicting results regarding the efficacy of creatine, we conducted a systematic review, which was updated in 2012. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Science communicators (journalists, bloggers, editors) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 118 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 21 | 18% |
Researcher | 15 | 13% |
Student > Bachelor | 15 | 13% |
Student > Ph. D. Student | 8 | 7% |
Other | 6 | 5% |
Other | 14 | 12% |
Unknown | 39 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 39 | 33% |
Nursing and Health Professions | 9 | 8% |
Biochemistry, Genetics and Molecular Biology | 6 | 5% |
Agricultural and Biological Sciences | 5 | 4% |
Neuroscience | 5 | 4% |
Other | 12 | 10% |
Unknown | 42 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2020.
All research outputs
#2,661,376
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#5,255
of 11,499 outputs
Outputs of similar age
#24,659
of 286,552 outputs
Outputs of similar age from Cochrane database of systematic reviews
#76
of 195 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,552 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 195 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.